Exercise Fights ‘Chemo Brain’: Study Shows Benefits During Cancer Treatment

The impact of cancer treatment extends far beyond the initial fight against the disease. Increasingly, research highlights the often-overlooked cognitive challenges many patients face long after remission – a phenomenon often called “chemo brain.” However, emerging evidence suggests a powerful, accessible intervention may help mitigate these effects: structured exercise. A new study published in the Journal of the National Comprehensive Cancer Network (JNCCN) confirms that even simple, adapted physical activity during chemotherapy can help preserve mental agility, reduce fatigue and improve daily functioning.

Cognitive Decline and Cancer Treatment: A Growing Concern

Cognitive impairment related to cancer (CRCI) affects a substantial number of individuals undergoing treatment. Estimates suggest that up to 75% of patients experience some degree of cognitive decline, impacting memory, attention, processing speed, and executive functions. These difficulties can persist for up to ten years after therapy concludes, significantly affecting daily life – from managing medications and finances to driving and maintaining work performance. The rising number of cancer survivors – currently at 17 million in the US, projected to reach 22 million by 2030 according to the National Cancer Institute – underscores the importance of addressing these long-term consequences of treatment.

Researchers at the Wilmot Cancer Institute at the University of Rochester led the recent study, a phase III trial involving 687 patients from 20 community oncology practices across the United States. Participants were randomly assigned to receive their standard chemotherapy regimen with or without the addition of a prescribed exercise plan, known as Exercise for Cancer Patients (Excap). This plan incorporated personalized walking routines and resistance band exercises.

Exercise Timing and Cognitive Benefits

The study revealed particularly striking results among patients undergoing chemotherapy in two-week cycles. Those who adhered to the Excap program reported less overall cognitive decline, improved self-perception of their mental abilities, and reduced mental fatigue compared to those who did not engage in structured exercise. Interestingly, the benefits were less pronounced in patients receiving chemotherapy in longer, three-to-four-week cycles. Researchers hypothesize that the shorter cycles may provide an optimal window for recovery and allow for greater adherence to the exercise program, maximizing its cognitive benefits.

This finding aligns with previous research linking exercise to improved cognitive function in other populations. Michelle Janelsins, Ph.D., M.P.H., of the University of Rochester Medical Center, has been a leading investigator in this field, previously demonstrating significant cognitive impairment in women undergoing breast cancer treatment and, separately, that regular exercise before a breast cancer diagnosis can reduce the risk of chemo brain. Further research from the Wilmot Cancer Institute has established a clear connection between lymphoma and chemo brain, highlighting the widespread nature of this issue.

How Exercise Protects the Brain During Chemotherapy

The study provides compelling evidence that exercise may interrupt the cycle of cognitive decline, in part by regulating the inflammatory response. Chemotherapy can disrupt the immune system, leading to persistent inflammation linked to cognitive impairment. Physical activity, conversely, triggers an anti-inflammatory response that supports immune function. This effect is believed to contribute to improvements in mental fatigue and cognitive performance.

Participants in the exercise program received individualized instructions on walking and resistance band use, employing a “teach-back” method to ensure proper technique. They likewise tracked their activity with a pedometer and recorded their resistance training time. Notably, whereas program participants maintained their baseline step counts, those who did not receive an exercise plan reduced their daily walking by 53% during chemotherapy.

Beyond Cognition: A Holistic Approach to Cancer Care

The benefits of exercise extend beyond cognitive function. Karen M. Mustian, a co-author of the study from the Wilmot Cancer Institute, emphasizes the importance of integrating exercise into routine cancer care. “A simple and safe program could be fundamental in supportive care for people receiving chemotherapy,” she stated. As reported by La Razón, Mustian recommends healthcare professionals educate patients about the benefits of exercise, monitor cognitive symptoms, and refer them to oncology exercise specialists when necessary.

Currently, We find limited standardized pharmacological treatments for cancer-related cognitive impairment, making non-invasive, accessible, and low-cost interventions like exercise particularly valuable. The ability to exercise at home further enhances adherence and reduces barriers related to travel or specialized facilities.

Spain’s Pioneering Role in Oncology Exercise

The integration of structured exercise programs into cancer care is gaining momentum globally. In Spain, numerous hospitals and centers are already developing and implementing such programs. Experts emphasize that this complementary therapy requires a tailored approach. Soraya Casla, a pioneer in the field, recently noted that “not all exercise is effective against cancer,” advocating for professionalized and personalized programs that adjust intensity and type of training to address chemotherapy-related side effects and individual patient limitations. La Razón details how these programs aim to reverse functional decline and improve key physiological factors related to tumor progression.

For example, the Gregorio Marañón Hospital in Madrid has implemented an innovative therapeutic exercise program for cancer patients. Physiotherapists, rehabilitation specialists, and occupational therapists design personalized routines combining strength and aerobic activity, even for patients actively undergoing chemotherapy. This multidisciplinary approach, which has already benefited over 100 patients, focuses on restoring lost functionality, improving treatment tolerance, and reducing side effects like muscle weakness, fatigue, and respiratory limitations. The center is also developing specific prehabilitation programs for cancer surgery and rehabilitative approaches for cancers of the esophagus, head and neck, or brain tumors.

Future Directions and Expanding the Evidence Base

Researchers acknowledge the need for further studies to broaden the patient population and generalize the findings. Exploring the relationship between chemotherapy schedules and the effectiveness of complementary interventions is also a priority. While the current study demonstrated benefits across various cancer types, the majority of participants were women with breast cancer receiving first-line chemotherapy without distant metastasis, which strengthens the conclusions but limits broad applicability.

The absence of standardized pharmacological treatments for CRCI reinforces the potential of exercise as a viable intervention. Ongoing research will continue to refine exercise protocols, identify optimal timing and intensity, and explore the underlying mechanisms driving these cognitive benefits. Healthcare providers are encouraged to discuss the potential benefits of structured exercise with patients undergoing chemotherapy, emphasizing the importance of personalized guidance and monitoring.